Growth factor plus preemptive ('just-in-time') plerixafor successfully mobilizes hematopoietic stem cells in multiple myeloma patients despite prior lenalidomide exposure.
| Autor: | Costa, L J1, Abbas, J1, Hogan, K R1, Kramer, C1, McDonald, K1, Butcher, C D1, Littleton, A1, Shoptaw, K1, Kang, Y1, Stuart, R K1 |
|---|---|
| Zdroj: | Bone Marrow Transplantation. Nov2012, Vol. 47 Issue 11, p1403-1408. 6p. 2 Charts, 3 Graphs. |
| Databáze: | Academic Search Ultimate |
| Externí odkaz: |
|